Enantioselective Synthesis Of Benzyl (1s,2r,4r)-4-(Tert-Butoxycarbonylamino)-2-(Hydroxymethyl)Cyclohexylcarba Mate Using An Iodolactamization As The Key Step

An efficient enantioselective synthesis of benzyl (1S,2R,4R)-4-(tert-butoxycarbonylamino)-2-(hydroxymethyl)cyclohexylcarbamate 2, art essential intermediate for a series of potent CCR2 antagonist;, is described. The key step in the sequence is all iodolactamization to yield the highly functionalized (1R,2S,4S,5S)-tert-butyl 2-(benzyloxycarbonylamino)-4-iodo-7-oxo-6-azibicyclo[3.2.1]octane-6-carboxylate 11. An examination of the reaction mechanism within the 2-step iodolactamization sequence led to the discovery of a single-pot transformation of increased efficiency.